Prime News recently interviewed Prof. Dr. Gregor Hutter, head of neurosurgery at University Hospital Basel, about his team’s groundbreaking work on a new immunotherapy for glioblastoma. In the feature, Prof. Hutter explains how the treatment — which will enter clinical trials next spring — could significantly extend survival for patients with aggressive brain tumors.
Listen to the full interview (in German) here